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ABSTRACT
p27
kip1 regulates cell proliferation by binding to and
inhibiting the activity of cyclin-dependent kinases
and its expression oscillates with cell cycle.
Recently, it has been suggested from studies using
the traditional dicistronic DNA assay that the expres-
sion of p27
kip1 is regulated by internal ribosome
entry site (IRES)-mediated translation initiation, and
several RNA-binding protein factors were thought to
play some role in this regulation. Considering the
inevitable drawbacks of the dicistronic DNA assay,
whichcouldmisleadapromoteractivityoralternative
splicing to IRES as previously demonstrated, we
decided to reanalyze the 50-untranslated region (50-
UTR) sequence of p27
kip1and test whetheritcontains
an IRES element or a promoter using more stringent
methods, such as dicistronic RNA and promoterless
dicistronic and monocistronic DNA assays. We
found that the 50-UTR sequence of human p27
kip1
does not have any significant IRES activity. The pre-
viously observed IRES activities are likely generated
from the promoter activities present in the 50-UTR
sequencesofp27
kip1.Thefindingsinthis studyindic-
ate that transcriptional regulation likely plays an
importantroleinp27
kip1expression,and themechan-
ism of regulation of p27 expression by RNA-binding
factors needs to be re-examined. The findings in this
study also further enforce the importance that more
stringent studies, such as promoterless dicistronic
and monocistronic DNA and dicistronic RNA tests,
arerequiredtosafeguardanyfutureclaimsofcellular
IRES.
INTRODUCTION
p27
kip1 (referred as p27) is an inhibitory protein of cyclin-
dependent kinases (Cdks) and it plays a key role in regulating
Cdk activity during cell cycle progression and in growth arrest
(1,2). The expression level of p27 is a critical determinant for
the decision of cells in G1 to either withdraw from or commit
to the cell cycle and enter S phase. The expression of p27
oscillates with cell cycle and is higher in G1 and lower in other
phases (3).
The regulation of p27 expression is precise and has been
suggested to occur at many levels, including translation ini-
tiation (4–6). In 1996, Agrawal et al. (4) and Hengst and Reed
(5) found that the expression of p27 may be regulated at the
translational level. Millard et al. (7) found that the translation
of p27 mRNA in both basal (proliferation) and induced
(nonproliferation) states required a U-rich sequence in the
50-untranslated region (50-UTR). Using a dicistronic DNA
vector, Miskimins et al. (8) found that an internal ribosome
entry site (IRES) element present in the 217 bases of the
50-UTR of mRNAs may be involved in the translational regu-
lation of murine p27. Using similar strategies, the IRES in the
50-UTR of human p27, however, was thought to be longer and
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doi:10.1093/nar/gki680it may consist of 356 bases (9). Recently, it was shown that an
upstream open reading frame (ORF) in the 50-UTR of human
p27 is important for the IRES activity (10).
Initiation of translation of most eukaryotic mRNAs norm-
ally depends on the 50 m
7GpppN cap structure of mRNAs,
which recruits 43S ribosome preinitiation complex via inter-
action with the cap binding protein eIF4E (11). The translation
machinery then migrates downstream until it meets the ﬁrst
AUG codon in the optimal context for initiation of translation
(12,13). This scanning model implies that any mRNAs with
long 50-UTRs and complex secondary structures may not be
translated efﬁciently. An alternative mechanism, IRES-
mediated translation initiation, has thus been proposed.
With this mechanism, ribosomes can be directly recruited
to an internal site in a 50-UTR sequence proximal to the
AUG start codon for initiation without the use of the 50-cap
structure. Up to date, many eukaryotic cellular mRNAs have
been suggested to contain such IRES activities (see http://
www.rangueil.inserm.fr/IRESdatabase). While it is possible
that some cellular mRNAs may use the IRES mechanism to
initiate translation (14), their existence has been challenged
due to the inevitable drawbacks of the conventional dicistronic
DNA assay used in the majority of these previous studies
(15–17). Despite such concerns, many new studies claiming
cellular IRES are being published without any rigorous ana-
lysis to rule out the potential interference of promoters and
alternative splicing events.
In the present study, we re-examined the 50-UTR sequence
of human p27 mRNA and further tested the putative IRES
activities using promoterless dicistronic and monocistronic
vectors and direct assays of dicistronic mRNAs. Using
these stringent assays, we found that the 50-UTR sequence
of human p27 does not have IRES activities but contains
promoters which may be involved in regulating p27 expres-
sion. These promoter activities are likely responsible for the
previously reported putative IRES activities of p27.
MATERIALS AND METHODS
Materials
Restriction endonucleases andPfu polymerase werepurchased
from New England Biolabs and Stratagene, respectively. Sp6
and T7 RNA polymerases, RNasin, RNase-free DNase I, Luci-
ferase Reporter Assay Systems, pGEM-T easy and pSP64
poly(A) vectors were from Promega. RNeasy kit and Oligotex
mRNA Mini kit were from Qiagen. MAXIscript in vitro tran-
scription kit and RPA III Ribonuclease Protection Assay Kit
were from Ambion. m
7GpppG cap analog and [a-
32P]dCTP
were from Amersham/Pharmacia. The Sephadex G-25 Quick
Spin Columns (TE) for radio-labeled DNA and RNA puriﬁca-
tion were from Roche Diagnostics. PCR Cloning kit, cell
culture media and sera, Lipofectamine Plus and Lipofectin
transfection reagents were all from Invitrogen. All other
reagents were of molecular biology grade from Fisher or
Sigma.
Construct engineering
The full-length sequence of 50-UTR of human p27 is 575 bases
(9). The full-length and the two deletion mutants of 50-UTR
sequences of human p27 were ampliﬁed from human genomic
DNA using a common reverse primer 50-GGCCATGGC-
TTTCTCCCGGGTCTGCACGA-30 and the following
individual forward primers: 50-GGACTAGTCCACCTTAAG-
GCCGCGCTCGC-30 for full-length ( 575 to  1) 50-UTR; 50-
GGACTAGTAGCCTCCCTTCCACCGCCATA-30 for dele-
tionconstruct( 461 to 1);and 50-GGACTAGTGGCCGTG-
GCTCGTCGGGGTCT-30 for deletion construct ( 150 to
 1). These PCR products were then cloned into pGEM-T
Easy vector.
To engineer dicistronic constructs containing different 50-
UTRs of human p27, the dicistronic vector pRF that contains
Renilla and ﬁreﬂy luciferase genes (18) was used. The full-
lengthandthe twodeletion constructsofhumanp2750-UTR in
pGEM-T Easy were released by digestion with SpeI and NcoI
and subsequently cloned into pRF vector to obtain pR-p27-
F( 575), pR-p27-F( 461) and pR-p27-F( 150). The pro-
moterless dicistronic constructs containing these 50-UTRs
were engineered by removing the vector SV40 promoter
together with the chimeric intron as described previously
(19). The hairpin structure in the dicistronic constructs were
engineered by cloning the 50-UTR sequences into the dicis-
tronic constructs containing a hairpin prepared in a previous
study (20). To generate constructs that can be used for in vitro
production of transcripts with poly(A) tail, the 50-UTR
sequences in the dicistronic constructs were released by diges-
tion with SpeI and NcoI and subsequently cloned into the
pSP-R-HRV-FA30 plasmid (19) by replacing the HRV IRES
sequence digested with SpeI and NcoI.
In vitro transcription
In vitro transcription was performed as described previously
(21). Brieﬂy, pRFA30-based plasmids were linearized by
EcoRI and the capped transcripts were synthesized in vitro in
the presence of 1 mM m
7GpppG. The DNA template was then
removed by digestion using RNase-free DNase I, and the RNA
transcripts were puriﬁed using a Qiagen RNeasy Mini kit.
Purification of recombinant human polypyrimidine
tract-binding protein (PTB) and in vitro translation
His-tagged PTB was expressed in Escherichia coli
BL21(DE3) cells using the pET28aPTB construct (22) and
puriﬁed using Ni-NTA Sepharose (Qiagen) according to the
supplier’s protocol. The puriﬁed His-PTB was extensively
dialyzed against H100 buffer (10 mM Tris–HCl, pH 7.4,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.1 mM phenyl-
methylsulfonyl ﬂuoride and 10 mg/ml leupeptin) prior to use
in the in vitro translation system.
In vitro translation was performed as described previously
(19,20,23). Brieﬂy, 100 ng of capped dicistronic RNA tran-
scripts were used to program cell-free translation in rabbit
reticulocyte lysate (RRL) in a ﬁnal volume of 10 ml containing
6.5 ml RRL. The translation mixture contained either 1 mlo f
H100 buffer (control) or 1 ml of puriﬁed His-PTB at 25 mg/ml.
Cell culture and transfections
Human large cell lung cancer cell line H1299 and human
embryonic kidney 293T cells were maintained in RPMI 1640
and DMEM media, respectively, supplemented with 10%
3764 Nucleic Acids Research, 2005, Vol. 33, No. 12fetal bovine serum in humidiﬁed incubators at 37 C with
5% CO2.
Transient transfection withDNA constructswere performed
with Lipofectamine plus reagents as described previously
(19,20,23). Brieﬂy,  6 · 10
4 cells/well in a 24-well plate
were co-transfected with 0.4 mg of test DNA and 50 ng of
b-galactosidase control DNA. Cells were then harvested 24 h
post-transfection followed by analysis of luciferase and
galactosidase activities.
Transient transfection with RNA transcripts were also
performed using cationic liposomes as described previously
(19,20,23). Brieﬂy,  3 · 10
5 cells/well were seeded onto
6-well plates on the day before transfection. Cells were
washed once with Opti-MEM I reduced serum medium
(Invitrogen) and left in the incubator with some medium dur-
ing preparation of the liposome-polynucleotide complexes.
One milliliter of Opti-MEM I medium in a 12 · 75 mm poly-
styrene snap-cap tube was mixed with 12.5 mg of Lipofectin
reagent and 5 mg of RNA transcripts. The liposome–RNA–
medium mixture was immediately added to cells. Eight hours
following transfection, cells were harvested and processed for
luciferase assay.
Luciferase reporter assay
Cells co-transfected with dicistronic or monocistronic reporter
plasmids and b-galactosidase control plasmid were lysed in
the Passive Lysis Buffer (Promega). Both the ﬁreﬂy (Fluc) and
Renilla luciferase (Rluc) activities were determined using the
Dual-Luciferase Reporter Assay kit as described previously
(19). The ﬁreﬂy luciferase activity from monocistronic con-
structs was determined using the Mono-Luciferase Reporter
Assay kit. The activity of b-galactosidase was measured as
described previously (24) and was used to normalize the
differences of transfection efﬁciency.
RNA extraction and RNase protection assay
Approximately 2 · 10
6 cells in 10 cm plates were transfected
with DNA (4 mg/plate) using Lipofectamine Plus reagent. At
48 hpost-transfection, cells were harvested andthe total RNAs
were extracted using an RNeasy Mini Kit. Potential contam-
inating plasmid DNA in the total RNAs was digested with
RNase-free DNase.
Ribonuclease Protection Assay (RPA) was performed using
the RPA III kit according to the manufacturer’s instruction.
To prepare RNA probe, the region between  277 and  1o f
human p27 50-UTR sequence and +1t o+133 in the ORF of the
ﬁreﬂy luciferase gene was ampliﬁed using PCR and cloned
into pGEM-T Easy vector. The resulting plasmid was linear-
ized with SpeI and labeled in vitro using T7 RNA polymerase
in the presence of 0.5 mM each of ATP, UTP, GTP and
0.01 mM CTP supplemented with 50 mCi [a-
32P]CTP. The
[a-
32P]labeled probe was digested with DNase I and puri-
ﬁed using a Sephadex G-25 Quick Spin Column. About
5 · 10
5 c.p.m. of probe was hybridized to 15 mg total RNA
at 45 C overnight followed by digestion with RNase T1/A for
35 min at 37 C. The reaction was then stopped and the pro-
tected RNA samples were separated by electrophoresis on a
6% acrylamide/8 M urea gel. The gel was then dried for
autoradiography.
RESULTS
The 50-UTR sequence of p27 enhances the expression of
the second cistron in the dicistronic DNA test
Dicistronic DNA test has been used in the previous studies to
show the existence of IRES activities in the 50-UTR sequence
of both human and murine p27, although it was thought that
the length of the IRES element may vary between the two
species (8,9). To further characterize the 50-UTR sequence, we
engineered three dicistronic constructs containing various
lengths of the 50-UTR sequence of human p27 (Figure 1B)
ﬂanked by Renilla and ﬁreﬂy luciferase genes (Figure 1A).
These constructs were then transfected into H1299 cells for
the analysis of potential IRES activity using luciferase assay.
As shown in Figure 1C and Table 1, the expression of the
second cistron ﬁreﬂy luciferase was greatly enhanced by the
presence of the p27 50-UTRs although the enhancement
decreased gradually with the truncation of sequence from
the 50 end. The expression of Renilla luciferase was not chan-
ged by the insertion of the 50-UTR sequence of p27. The
increased ratio of ﬁreﬂy to Renilla luciferase activities by
the 50-UTR sequence of p27 compared with vector control
suggests that there may be an IRES element in these sequences
(Figure 1D). Insertion of a hairpin in front of the ﬁrst cistron
did not affect the expression of the second cistron ﬁreﬂy luci-
ferase (data not shown). These observations are consistent
with the previous ﬁndings and with the claim of the existence
of IRES activity in the 50-UTR sequence of p27 (8–10).
The 50-UTR of p27 does not display an IRES activity in
the dicistronic mRNA assay
The above studies suggest that the 50-UTR of p27 may contain
an IRES element. However, the enhanced expression of the
second cistron could also be due to the existence of promoters
in the 50-UTR or due to alternative splicing of the dicistronic
transcripts as suggested previously (15–17,19). To further
determine whether the 50-UTR of p27contains IRES activities,
we performed a more stringent dicistronic mRNA test, which
allowsadirect analysiswhetherthe 50-UTRsequenceofp27in
the intergenic region can increase the translation of the second
cistron ﬁreﬂy luciferase without the transcriptional and spli-
cing interference. For this purpose, we engineered additional
constructs for making in vitro dicistronic transcripts contain-
ing 50-caps and 30-poly(A) tails (Figure 2A). In addition, a
well-known viral HRV IRES sequence was also cloned into
the intergenic region to serve as a positive control. These
in vitro transcripts were then transfected into H1299 cells,
which were then harvested for luciferase assay. As shown
in Figure 2B and C, the expression of the second cistron ﬁreﬂy
luciferase was enhanced only by the HRV IRES as expected.
None of the 50-UTR sequences of p27 enhanced the expression
of the second cistron ﬁreﬂy luciferase. Thus, it is likely that
the 50-UTR of p27 does not contain a functional IRES element
as previously thought.
The 50-UTR sequence of p27 contains functional
promoter elements in promoterless dicistronic DNA
assay
The above results of dicistronic mRNA assay prompted us
to investigate whether the 50-UTR sequence of p27 contains
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lation of expression of the second cistron ﬁreﬂy luciferase in
the dicistronic DNA assays (Figure 1). For this purpose,
we ﬁrst engineered promoterless dicistronic constructs as
described previously (19,20) by simply removing the unique
SV40 promoter together with the intron sequence from the
pRF-based dicistronic constructs (Figure 3A). These pro-
moterless dicistronic constructs will not generate dicistronic
mRNAsafter transfectionintocellsduetothelackoftheSV40
promoter. Thus, the activity of any potential IRES element in
the constructs should not be detected. Any expression of the
second cistron ﬁreﬂy luciferase from these promoterless dicis-
tronic DNAs will be due to the existence of a promoter in the
50-UTR sequence of p27. As shown in Figure 3B and C, the
enhanced expression proﬁle of the second cistron ﬁreﬂy
luciferase in the promoterless construct is similar to that gen-
erated in the presence of the SV40 promoter (compare with
Figure 1). The actual ﬁreﬂy luciferase activities are similar to
that generated in the presence of SV40 promoter, whereas the
actual Renilla luciferaseactivityisdrastically decreaseddue to
the removal of the vector promoter (see Table 1). Thus, the
50-UTR sequence of p27 likely contains promoters.
To ensure that the above observations are not speciﬁc to the
cell line used, we performed similar studies using 293T cells,
which has been used in a previous study of p27 50-UTR (25).
First, dicistronic mRNAs were transfected into 293T cells and
Figure 1. Dicistronic DNA test of the 50-UTR sequence of human p27. (A) Schematic diagram of dicistronic DNA constructs without (pRF) or with the insert of
50-UTRofp27(pR-P27-F)intheintergenicregion.Thelocationsofseveralrelevantrestrictionenzymesitesareshownbyarrows.(B)Schematicdiagramofdeletion
ofthe50-UTRsequenceofp27.Thedeletionswerefromthe50 endofthesequencewiththepositionsofdeletionindicated.(C)Relativeluciferaseactivitiesgenerated
bythedicistronicDNAconstructs.H1299cellsweretransfectedwithpRFandpR-P27-Fconstructs.Twenty-fourhoursfollowingtransfection,cellswereharvested
andtheRenillaandfireflyluciferasesactivitiesweremeasured.Firefly(filledbars)andRenilla(openbars)luciferaseactivitieswerenormalizedtotheco-transfected
b-galactosidase activity and then to that generated by the vector (RF). (D) Relative F/R luciferase activity ratios. The relative ratios of firefly and Renilla luciferase
activities were calculated and normalized to that of the vector-transfected cells (RF). The data were from one of the four independent experiments. R, Renilla;F ,
firefly.
Table 1. Luciferase activities of various constructs in H1299 and 293T cells
RF RP27F( 575) RP27F( 461) RP27F( 150)
Fluc (+P)
a 485
b 75576 46340 7836
Rluc (+P)
a 132334 164179 157607 167983
Fluc ( P)
a 293 82575 34486 6893
Rluc ( P)
a 372 333 274 407
Fluc ( P)
c 519 611571 98286 3858
Rluc ( P)
c 435 417 344 413
aLuciferase activities were measured from lysates prepared from H1299 cells
transfected with various constructs and the values were normalized with
b-galactosidaseactivitiestoadjusttransfectionefficiency.+Pand Prepresent
constructs with and without the vector promoter, respectively.
bThe data presented in this table are from one representative experiment.
cLuciferase activities were measured from lysates prepared from 293T cells
transfected with various constructs and the values were normalized with
b-galactosidase activities to adjust transfection efficiency.
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showninFigure4A and B,the expression ofthe second cistron
ﬁreﬂy luciferase was enhanced only by the HRV IRES as
expected. None of the 50-UTR sequences of p27 enhanced
the expression of the second cistron ﬁreﬂy luciferase in 293T
cells. These observations are consistent with the data shown
using H1299 cells (compare with Figure 2). We next trans-
fected the promoterless dicistronic constructs into 293T cells
and determined luciferase activities. As shown in Figure 4C,
the ﬁreﬂy luciferase expression was enhanced by the presence
of the 50-UTR sequence of p27 in the intergenic region, sug-
gesting the presence of promoter activities (see also Table 1).
This observation is also similar to that generated in H1299
cells (compare with Figure 3). In fact, the promoter activity in
the longest form of 50-UTR of p27 as indicated by the ﬁreﬂy
luciferase activity is much more pronounced in 293T cells
compared with H1299 cells, although the shorter 50-UTR seg-
ments had similar activities in the two cell lines (see Table 1).
Similar observations have also been made with HeLa cells that
were usedin two other previous studies (9,10).Taken together,
we conclude that the previous ﬁndings of the putative ‘IRES’
activities in the 50-UTR sequence of p27 was not due to the
Figure 2. Dicistronic mRNA test of the 50-UTR of human p27 in H1299 cells.
(A) Schematic diagram of the dicistronic mRNA used for translation in H1299
cells.Invitrotranscriptswith50-cap(m
7GpppG)and30-poly(A)tail(A30)were
synthesized using Sp6 RNA polymerase from linearized vector alone (RFA30),
constructs containing the IRES of HRV (R-HRV-FA30) or the 50-UTRs of p27
(R-P27-FA30). (B) Relative luciferase activities from dicistronic mRNAs in
H1299 cells. H1299 cells were transfected with the dicistronic mRNAs, and
8 h following transfection Renilla and firefly luciferase activities were meas-
ured and normalized to that of vector control (RF). (C) Relative F/R luciferase
activityratios.TheratiosofrelativefireflyandRenillaluciferaseactivitieswere
calculated and normalized to that of the control vector-transfected cells (RF).
Figure 3. PromoterlessdicistronicDNAtestofthe50-UTRsequenceofhuman
p27. (A) Schematic diagram of promoterless dicistronic DNA constructs with-
out insert [pRF( P)] or with the 50-UTR of p27 [pR-P27-F( P)] in the inter-
genic region. (B) Relative luciferase activity generated by the promoterless
dicistronic DNA constructs. H1299 cells were transfected with pRF( P) and
pR-P27-F( P) constructs. Twenty-four hours following transfection, cells
were harvested and the Renilla and firefly luciferases activities were meas-
ured. The firefly (filled bars) and Renilla (open bars) luciferase activities
were normalized to the co-transfected b-galactosidase activity and then to
that generated by the vector (RF). (C) The relative ratios were calculated
and normalized to that of the vector-transfected cells [RF( P)]. The data were
from one of the four independent experiments. R, Renilla; F, firefly.
Figure 4. Dicistronic mRNA and promoterless dicistronic DNA test in
293T cells and in vitro.( A and B) Relative luciferase activity from dicistronic
mRNAs in 293T cells. In vitro dicistronic transcripts were prepared as
described in Figure 2 and transfected into 293T cells. Eight hours following
transfection,Renillaandfireflyluciferaseactivitiesweremeasuredandnormal-
ized to the co-transfected b-galactosidase and then to the vector control (RF)
(A). The ratios of relative firefly and Renilla luciferase activities were calcu-
latedandnormalizedtothatofthecontrolvector-transfectedcells(RF)(B).(C)
RelativeluciferaseactivitiesfrompromoterlessdicistronicDNAsin293Tcells.
293T cells were transfected with promoterless dicistronic constructs and luci-
ferase activities were determined as described in Figure 3. Firefly and Renilla
luciferase activities were normalized to the co-transfected b-galactosidase ac-
tivity and then to the vector control [RF( P)]. The relative ratios were calcu-
lated and normalized to that of the vector-transfected cells [RF( P)]. (D)
Relative luciferase activity from dicistronic mRNAs in vitro. Dicistronic
mRNAs containing the full-length 50-UTR (575 bases) of p27 or the HRV
IRES in the intergenic region were used to program translation in RRL in
the absence or presence of recombinant PTB as described in Materials
and Methods. Firefly and Renilla luciferase activities were determined
and the relative ratios were calculated and normalized to the control in the
absence of PTB.
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from the promoter activities.
Recently, it was suggested that PTB enhanced the putative
IRES activity of p27 50-UTR in cell-free expression system
and in vivo (25). We performed similar studies by translating
dicistronic RNA transcripts in RRL in the absence or presence
of puriﬁed PTB with HRV IRES as a positive control. Previ-
ously, we and others have observed that the HRV IRES is
inactive in RRL unless HeLa cell extracts or PTB is added
(19,26,27) (Figure 4D and Table 2). Contrary to the previous
ﬁnding by Cho et al. (25), we did not observe any enhanced
expression of the second cistron ﬁreﬂy luciferase by the
50-UTR of p27 in the absence or presence of PTB
(Figure 4D). In fact, the ﬁreﬂy luciferase activity generated
is very low, >500-fold less than the Renilla luciferase activity
(Table 2).
Existence of promoters in the 50-UTR of p27 as revealed
by RNAse protection assay
To conﬁrm the above conclusion that the 50-UTR of p27
contains promoters, we further tested if the transcripts with
only the second cistron ﬁreﬂy luciferase exist in the cells
transfected with dicistronic DNA constructs. RNase protection
assay was performed on total RNAs isolated from H1299 cells
following transfection with the traditional and promoterless
dicistronic constructs using a RNA probe covering the region
between  277 and  1 of human p27 50-UTR sequence and
the region between +1 and +133 of ﬁreﬂy luciferase ORF
(Figure 5A). As shown in Figure 5B, a short fragment with
an estimated size of 124 bases was produced from the tradi-
tional dicistronic vector (lane 4), which represents the protec-
ted luciferase gene from the dicistronic RNA transcripts. This
product is barely detectable with the RNA isolated from cells
transfected with the promoterless dicistronic vector (lane 8),
suggesting that the functional SV40 promoter has been suc-
cessfully removed. A fragment with an estimated size of
415 bases was produced from the traditional dicistronic con-
structs containing the 575 and 461 bases of p27 50-UTRs
(lanes 5 and 6). This product is likely generated from the
dicistronic RNA produced using the vector SV40 promoter.
However, a similar product, albeit with less intensity, was also
observed with the promoterless dicistronic construct (lane 9),
suggesting that a transcription start site may exist upstream of
the probe used (Figure 5A, the marker X). Four fragments of
272, 258, 184 and 166 bases were also produced with both
the traditional and the promoterless dicistronic constructs con-
taining 575 and 461 bases of p27 50-UTRs (lanes 5, 6, 9 and
10), suggesting that four transcription start sites likely exist at
around  139,  125,  51 and  33. Interestingly, for the
traditional dicistronic construct containing only 150 bases
of the p27 50-UTR (lane 7), only the product of 184 bases
was observed, suggesting that except the transcription start
site  51, all others are silent in this construct. The product
of 290 bases (lane 7) was likely generated from the protection
of the dicistronic RNA transcripts containing 150 bases of p27
50-UTR. It appears that the shortest 50-UTR segment ( 150) in
the promoterless construct apparently has promoter activity
(Figure 3) but it is too weak for direct RNA analysis to detect
the transcript (Figure 5, lane 11). It is possible that the tran-
scription start site at  51 requires the vector SV40 promoter
and/or the upstream p27 promoters, which may function as
regulatory promoters (28). It is also possible that the produc-
tion of the 184 bases fragment from the shortest traditional
dicistronic construct was due to potential alternative splicing,
which is absent with the removal of sequences together with
the SV40 promoter in the shortest promoterless dicistronic
plasmid (see below).
To further conﬁrm the promoter activities in the 50-UTR
sequence of p27, we cloned these sequences into the standard
promoter-testing monocistronic vector pGL3, which does not
have any promoter element. These constructs containing the
different sizes of p27 50-UTR were then transfected into
Table 2. Luciferase activities of dicistronic RNAs generated in RRL
HRV ( PTB) HRV (+PTB) p27( PTB) p27(+PTB)
Fluc 1898
a 4626 2123 2179
Rluc 988828 1380389 1057596 1207663
aThe data presented in this table are from one representative experiment.
Figure 5. RNase protection assay of p27 50-UTR in dicistronic constructs. (A)
Schematic diagram illustrating the location of transcription start sites and the
probe used for RNase protection assay. X indicates an upstream transcription
start site. (B) RNase protection assay. Total RNAs were isolated from H1299
cells following transfection with dicistronic vector pRF (lane 4), pR-P27-F
(lanes5–7),promoterlessdicistronicvectorpRF( P)(lane8),andpromoterless
pR-P27-F(lanes9–11)andthenusedforRNaseprotectionassayasdescribedin
MaterialsandMethods.Lanes1–3are controlreactionswithout(lanes1and2)
or with (lane 3) RNase in the absence (lane 1) or presence (lanes 2–3) of yeast
RNA.
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shown in Figure 6B, similar ﬁreﬂy luciferase activities were
observed with these constructs compared with that generated
from the traditional and promoterless dicistronic constructs
(compare with Figures 1 and 3). RNase protection analysis
of the RNAs isolated from cells transfected with these mono-
cistronic constructs also showed the production of various
transcription products similar to that shown with the dicis-
tronic constructs (compare Figure 6C with Figure 5) although,
again, the shortest 50-UTR segment had promoter activity
which is too weak to be detected by direct RNA analysis.
Based on the above observations with promoterless dicis-
tronic and the standard promoter-testing monocistronic con-
structs, we conclude that the 50-UTR sequence of human p27
contains promoter activities that can initiate transcription at
several sites. Transcription at these sites in the dicistronic
DNA assay generates monocistronic transcripts containing
only the ﬁreﬂy luciferase gene with short 50-UTRs that can
be translated easily using the scanning mechanism (12,13).
These shorter monocistronic RNA transcripts are likely
responsible for the enhanced expression of ﬁreﬂy luciferase
in the dicistronic DNA test and they may represent the pre-
viously reported IRES activity.
DISCUSSION
In this work, we studied the 50-UTR sequence of human
p27 mRNA and further tested the putative IRES activity
using promoterless dicistronic and monocistronic vectors and
direct assay of dicistronic mRNAs. Our results indicated that
the 50-UTR sequence of p27 contains promoters that can drive
production of abundant monocistronic transcripts with shorter
50-UTRs. These ﬁndings raise questions on the IRES activity
of the 50-UTR sequence of p27 reported previously using the
traditional dicistronic DNA assay.
Use of IRES for translating the untranslatable cellular
mRNAs with long 50-UTRs is an interesting concept (29).
The use of such a mechanism for translating polycistronic
viral RNAs has been convincingly demonstrated previously
(30). However, whether cellular mRNAs also use this mech-
anism is currently under debate (15,31). The central problem
associated with the majority of studies claiming cellular IRES
is the use of traditional dicistronic DNA test which does not
directly test the translation. Potential promoter activities
and alternative splicing could both contribute to the observed
‘IRES’ activity. These potential problems have recently been
demonstrated on several previously believed-to-be cellular
IRES elements. These IRES activities were shown to be due
to cryptic promoters present in the 50-UTRs (19,23,32–34) or
due to differential splicing (35) which would create smaller
monocistronic transcripts from the dicistronic DNAs for
potential cap-dependent translation initiation of the second
cistron. In one of these studies, the prevailing cellular IRES
sequence of eIF4G (36,37) was shown to be an C/E BP beta
transcription factor binding site (19). In another study, the
strong IRES activity in the 50-UTR of XIAP mRNAs was
found to be mostly due to alternative splicing (35). Further-
more, a promoter activity was also found in the 50-UTR
sequence of hepatitis C virus, which has previously been
shown to have IRES activities (38). While these studies do
not necessarily exclude in general the existence of IRES in
cellular mRNAs per se, they necessitate more stringent studies
such as tests using promoterless dicistronic DNA transfection,
dicistronic RNA transfection and RT–PCR for safeguarding
any claims of cellular IRES.
Figure 6. Promoteractivityofp2750-UTRinmonocistronicconstructsandRNaseprotectionassay.(A)Schematicdiagramillustratingthelocationoftranscription
start sites and the probe used for RNase protection assay. X indicates an upstream transcription start site. (B) Luciferase assay. H1299 cells were transfected with
vectorpGL3andmonocistronicconstructsthatharboringthe50-UTRsequencesofp27.Forty-eighthoursfollowingtransfection,cellswereharvestedandluciferase
activitiesweremeasured.Theluciferaseactivitieswerethennormalizedtotheco-transfectedb-galactosidaseactivityandthentothatgeneratedbythevector(pGL3).
(C) RNaseprotectionassay. TotalRNAswere isolatedfollowingtransfection withthevector pGL3(lane1) andconstructscontainingthe50-UTRsequencesof p27
(lanes 2–4) and then used for RNase protection assay as described in Materials and Methods.
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ine p27 were reported to contain IRES activities using tradi-
tional dicistronic DNA assays (8,9). While the IRES in the
mouse p27 was thoughtto be located in the 217 bases proximal
to the AUG start codon, the full IRES activity in human p27
was thought to be located within the 356 bases upstream of
the start codon. However, in the present study, we showed that
these previously reported IRES activities are likely due to the
promoters present in the 50-UTR sequence of p27 (see below).
In the case of human p27, the deletion analysis showed that the
184bases upstreamofthe AUG start codon contains about half
of the putative IRES activity with a 15-fold stimulation of
Fluc/Rluc ratiobythe 50-UTRofp27comparedwith thevector
(9). This extent of stimulation is similar to the promoter activ-
ity we found using the dicistronic construct containing the
150 bases of human p27 50-UTR (see below). Furthermore,
no stimulation of the second cistron was observed with the
50-UTR of p27 in the dicistronic RNA assay (Figure 2). In fact,
the translation of the second cistron was inhibited in the dicis-
tronicRNAassaybyinsertingthe50-UTRsequenceofp27into
the intergenic region. These observations further suggest that
the 50-UTR of human p27 may not contain any signiﬁcant
IRES element as previously thought.
Using both the promoterless dicistronic vector and the
standard promoter-testing monocistronic vector pGL3, we
demonstrated that the 50-UTR of p27 contains promoters to
stimulate the transcription of its following sequences.
Because deletion of the ﬁrst 114 bases reduced by about
half the activity to stimulate the expression of ﬁreﬂy luciferase
gene, it is likely that the 575 bases of the 50-UTR sequence of
p27 contain a promoter at the 50 end, which is absent in the
construct harboring the 30 461 bases of the 50-UTR sequence.
Indeed, we found by RNase protection assay that a transcrip-
tion start site exists upstream of our probe (marked as X in
Figure 5A). Furthermore, Kullmann et al. (9) also found that
the 575 bases of the human p27 50-UTR contains a promoter
that is absent in the 461 bases of p27 50-UTR, consistent with
our ﬁndings. Further deletion at the 50 end from  461 to  150
drastically reduced the activity in stimulating the luciferase
expression. This observation suggests that the cryptic pro-
moters likely exist in the region between  461 and  150.
This conclusion is conﬁrmed by RNase protection assay,
which showed that two transcription start sites at positions
 125 and  139 are present in both the 575 and 461 constructs
but they are missing in the  150 construct (Figure 5). It is,
however, noteworthy that the remaining 150 bases in the
50-UTR of human p27 still stimulate the expression of the
luciferase reporter albeit at a much reduced level compared
with the longer sequences, suggesting that another promoter
likely exists in the 150 bases upstream of the AUG start codon.
RNase protection assay conﬁrmed that there is indeed a
transcription start site at about  51 in all three constructs.
However, this promoter activity appears to be very weak in
the absence of upstream promoters, such as the vector SV40
promoter or promoters present in the upstream sequence of
p27 50-UTR. It, thus, remains to be determined whether these
putative promoters have any physiological roles in regulating
p27 expression. The use of these promoters may generate
transcripts with shorter 50-UTRs, which can be efﬁciently
translated using the cap-dependent scanning model for trans-
lation initiation. Production of these shorter transcripts may be
important forthe increased expression ofp27 during G1 phase.
We are currently testing these possibilities and working
toward this direction.
Protein factors have been suggested to be involved in the
putative ‘IRES’ activity of p27. Several mRNA-binding pro-
teins, HuR, HuD and hnRNP C1/C2 (7,9), and more recently
PTB (25), were found to interact with the 50-UTR of p27 and
shown to either repress or enhance p27 expression. However,
using in vitro translation system we found no evidence that
PTB stimulates the expression of the second cistron ﬁreﬂy
luciferase of the dicistronic RNA containing the 50-UTR of
p27. Furthermore, the ﬁnding of cryptic promoters in the
50-UTR sequence of p27 urges the need to re-evaluate the
mechanism how these factors regulate p27 expression.
Because all the previous claims are based on transfections
using DNA reporter constructs, the effect of these factors
on transcription using the promoters in the 50-UTR of p27
could not be ruled out. Thus, the effect of these factors on
the expression of endogenous p27 might in fact be mediated
through mechanisms other than the putative ‘IRES’. HuR and
HuD are the AU-rich element-binding protein (39), which may
affectthe p27 expressionthrough binding tothe30-UTR ofp27
mRNA. However, PTB and hnRNP-C (40,41) are the known
factors associated with RNA splicing and they may affect the
expression of p27 by affecting the splicing of p27 mRNAs.
Sequence examination showed that the 50-UTR of p27 con-
tains two potential splicing acceptor sites close to the AUG
start codon. One is located at  114 to  129, while the other is
at  37 to  52. Alternatively, these factors may affect the
expression of other unknown factors, which indirectly contrib-
utes to p27 expression regulation. We propose that the effect
of these factors on p27 expression need to be re-evaluated in
the future by performing more stringent experiments, such as
using transfection of RNA transcripts instead of DNA
constructs and by testing the possibility of their effects on
transcription and splicing of p27 mRNAs.
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